Johnson & Johnson

JNJ

$163.87

+10.9% (1 year change)

Market Cap

$421 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$130.31 - $178.93

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

23.72x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$4.10 (2.56%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $421 Billion
Enterprise Value $430 Billion
Dividend Yield $4.10 (2.56%)
1 Year Return +13.4%
52-Week High $178.93
52-Week Low $130.31
Beta 0.51
Outstanding Shares 2.63 Billion
Avg 30 Day Volume 6.42 Million

Valuation

P/E Ratio 23.72
PEG 32.44
Earnings per Share $6.65
Price to Sales Ratio 4.97
Price to Book Ratio 6.3
Revenue to Enterprise Value 4.82
EBIT to Enterprise Value 18.75
Total Debt to Enterprise Value 0.08
Debt to Equity 0.48

Profitability

Revenue $89.2 Billion
Gross Profit $59.8 Billion
EBIT $22.9 Billion
Net Income $17.8 Billion
Profit Margin 19.92%
Quarterly Earnings Growth (YoY) +73.1%
Return on Equity 25.53%
Return on Assets 10.07%
Return on Invested Capital 16.64%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Johnson & Johnson

CEO: Alex Gorsky

Industry: Pharmaceutical Preparation Manufacturing

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Similar stocks

Pfizer Inc.
Merck & Co Inc
Novartis AG - ADR
Sanofi - ADR
Stryker Corp.
Medtronic Plc
Lilly(Eli) & Co
Abbott Laboratories
Glaxosmithkline plc - ADR
Gilead Sciences, Inc.

News

Washington State Fires Football Coach for Refusing to Get Vaccinated

Washington State Fires Football Coach for Refusing to Get Vaccinated

Kwhen Finance Kwhen Finance, 1 day ago
Johnson & Johnson (JNJ Stock) Q3 2021 earnings report outlook

Johnson & Johnson (JNJ Stock) Q3 2021 earnings report outlook

Johnson & Johnson is scheduled to report Q3 2021 results on Tuesday, October 19. In the previous report for Q2 in July, the company reported sales of

FXStreet FXStreet, 2 days ago
WSU coach''s status unclear facing vax deadline

WSU coach''s status unclear facing vax deadline

Kwhen Finance Kwhen Finance, 3 days ago